Luye Pharma Group Ltd operates as an investment holding company principally engaged in the development, production, marketing and sale of pharmaceutical products. The company operates through its four segments including : research, development, production and sale of pharmaceutical drugs for the fields of orthopaedics, neurology, gastroenterology and hepatology, focusing on natural drugs and chemical drugs with new formulations; distribution of products of other pharmaceutical manufacturers in China; processing and sale of active ingredients, mainly chondroitin sulphate, for the manufacture of pharmaceutical drugs; sale of R&D results and/or patents of new drugs and provision of research services on a contract basis. Luye Pharma Group Ltd was delisted from Singapore Stock Exchange on 6 November 2012. The company was listed in Hong Kong. Luye Pharma Group Ltd was incorporated in 2003 and is based in Singapore.
No. 15 Chuang Ye Road,High-Tech Industrial Development Zone,Yantai, Shandong
Heze; Shandong; Postal Code: 264003
Contact Details: Purchase the Luye Pharma Group Ltd report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service